For instance, Novartis reported encouraging interim data in January 2024 from the Phase 3 THALES trial, which assessed crizanlizumab (SEG101) for the avoidance of vaso-occlusive crises (VOCs) in ...
19m
The defense ministers of France and Indonesia agreed Friday to work more closely to maintain regional stability, Indonesian officials said.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback